| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.082 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |